These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 2790828)
1. Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer. Byers VS; Rodvien R; Grant K; Durrant LG; Hudson KH; Baldwin RW; Scannon PJ Cancer Res; 1989 Nov; 49(21):6153-60. PubMed ID: 2790828 [TBL] [Abstract][Full Text] [Related]
2. Toxicity and immunogenicity of monoclonal antimelanoma antibody-ricin A chain immunotoxin in rats. Harkonen S; Stoudemire J; Mischak R; Spitler LE; Lopez H; Scannon P Cancer Res; 1987 Mar; 47(5):1377-82. PubMed ID: 3493064 [TBL] [Abstract][Full Text] [Related]
3. Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin. Spitler LE; del Rio M; Khentigan A; Wedel NI; Brophy NA; Miller LL; Harkonen WS; Rosendorf LL; Lee HM; Mischak RP Cancer Res; 1987 Mar; 47(6):1717-23. PubMed ID: 3493066 [TBL] [Abstract][Full Text] [Related]
4. Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate. Weiner LM; O'Dwyer J; Kitson J; Comis RL; Frankel AE; Bauer RJ; Konrad MS; Groves ES Cancer Res; 1989 Jul; 49(14):4062-7. PubMed ID: 2786751 [TBL] [Abstract][Full Text] [Related]
5. In vivo therapy of the BCL1 tumor: effect of immunotoxin valency and deglycosylation of the ricin A chain. Fulton RJ; Uhr JW; Vitetta ES Cancer Res; 1988 May; 48(9):2626-31. PubMed ID: 3258547 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of growth of human tumor xenografts in athymic mice treated with ricin toxin A chain-monoclonal antibody 791T/36 conjugates. Byers VS; Pimm MV; Scannon PJ; Pawluczyk I; Baldwin RW Cancer Res; 1987 Oct; 47(19):5042-6. PubMed ID: 3497715 [TBL] [Abstract][Full Text] [Related]
7. Humoral immune responses to XMMCO-791-RTA immunotoxin in colorectal cancer patients. Durrant LG; Byers VS; Scannon PJ; Rodvien R; Grant K; Robins RA; Marksman RA; Baldwin RW Clin Exp Immunol; 1989 Feb; 75(2):258-64. PubMed ID: 2784738 [TBL] [Abstract][Full Text] [Related]
8. Single-dose murine monoclonal antibody ricin A chain immunotoxin in the treatment of metastatic melanoma: a phase I trial. Gonzalez R; Salem P; Bunn PA; Zukiwski AA; Lamb R; Benjamin RS; Spitler L; Wedel N; Robinson WA Mol Biother; 1991 Dec; 3(4):192-6. PubMed ID: 1768370 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo antitumor activity of ZENECA ZD0490, a recombinant ricin A-chain immunotoxin for the treatment of colorectal cancer. Calvete JA; Newell DR; Wright AF; Rose MS Cancer Res; 1994 Sep; 54(17):4684-90. PubMed ID: 8062265 [TBL] [Abstract][Full Text] [Related]
10. Human antibody responses to components of the monoclonal antimelanoma antibody ricin A chain immunotoxin XomaZyme-MEL. Mischak RP; Foxall C; Rosendorf LL; Knebel K; Scannon PJ; Spitler LE Mol Biother; 1990 Jun; 2(2):104-9. PubMed ID: 2363853 [TBL] [Abstract][Full Text] [Related]
11. Phase I immunotoxin trial in patients with B-cell lymphoma. Vitetta ES; Stone M; Amlot P; Fay J; May R; Till M; Newman J; Clark P; Collins R; Cunningham D Cancer Res; 1991 Aug; 51(15):4052-8. PubMed ID: 1855219 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin. Wawrzynczak EJ; Cumber AJ; Henry RV; May J; Newell DR; Parnell GD; Worrell NR; Forrester JA Cancer Res; 1990 Dec; 50(23):7519-26. PubMed ID: 2253201 [TBL] [Abstract][Full Text] [Related]
13. Phase I study of monoclonal antibody-ricin A chain immunoconjugate Xomazyme-791 in patients with metastatic colon cancer. LoRusso PM; Lomen PL; Redman BG; Poplin E; Bander JJ; Valdivieso M Am J Clin Oncol; 1995 Aug; 18(4):307-12. PubMed ID: 7625372 [TBL] [Abstract][Full Text] [Related]
14. Mediation of reduction of spontaneous and experimental pulmonary metastases by ricin A-chain immunotoxin 45-2D9-RTA with potentiation by systemic monensin in mice. Roth JA; Ames RS; Fry K; Lee HM; Scannon PJ Cancer Res; 1988 Jun; 48(12):3496-501. PubMed ID: 3259469 [TBL] [Abstract][Full Text] [Related]
15. The effects of cyclophosphamide on the toxicity and immunogenicity of ricin A chain immunotoxin in rats. Stoudemire JB; Mischak R; Foxall C; Harkonen WS; Del Rio M; Spitler LE Mol Biother; 1990 Sep; 2(3):179-84. PubMed ID: 2222902 [TBL] [Abstract][Full Text] [Related]
16. An immunotoxin cytotoxic for breast cancer cells in vitro. LeMaistre CF; Edwards DP; Krolick KA; McGuire WL Cancer Res; 1987 Feb; 47(3):730-4. PubMed ID: 3492266 [TBL] [Abstract][Full Text] [Related]
17. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain. Ramakrishnan S; Houston LL Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765 [TBL] [Abstract][Full Text] [Related]
18. Biodistribution of ricin toxin A chain-monoclonal antibody 791T/36 immunotoxin and influence of hepatic blocking agents. Byers VS; Pimm MV; Pawluczyk IZ; Lee HM; Scannon PJ; Baldwin RW Cancer Res; 1987 Oct; 47(20):5277-83. PubMed ID: 3498532 [TBL] [Abstract][Full Text] [Related]
19. Endocytosis of immunotoxin-791T/36-RTA by tumor cells in relation to its cytotoxic action. Byers VS; Pawluczyk IZ; Hooi DS; Price MR; Carroll S; Embleton MJ; Garnett MC; Berry N; Robins RA; Baldwin RW Cancer Res; 1991 Apr; 51(8):1990-5. PubMed ID: 2009518 [TBL] [Abstract][Full Text] [Related]
20. Analysis of gp74 expression by transformed rat fibroblasts from experimental pulmonary metastases following specific ricin A-chain immunotoxin therapy. Roth JA; Thomsen S; Fry KD; Scannon P; Chang C Cancer Res; 1989 Oct; 49(20):5708-12. PubMed ID: 2676148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]